Brief: Genmab Q1 Darzalex Net Sales At $3,964 Mln
April 14 (Reuters) - Genmab A/S GMAB.CO: ANNOUNCES NET SALES OF DARZALEX® (DARATUMUMAB) FOR FIRST QUARTER OF 2026 NET SALES OF DARZALEX® IN Q1 OF 2026 TOTALED USD 3,964 MILLION Source text: ID:nGNE5KW3H7 Further company coverage: GMAB.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Genmab A/S
See all newsBrief: Genmab Q3 Net Sales Of Darzalex At $4.24 Bln
European shares rise as retreating bond yields and oil prices boost risk appetite
Live Markets: Oil prices can rise even with a new MoU
Live Markets: What the AI capex cycle might mean for European growth
Live Markets: Ignore politics and buy the dip in Spain's Bonos